Usefulness of the Chronic Obstructive Pulmonary Disease-population (COPD-PS) Questionnaire and the COPD-6 Device in the Chronic Obstructive Pulmonary Disease Detection in a Tobacco Detoxication Consultation

• Conditions: Chronic Obstructive Pulmonary Disease
• Interventions: Other: Chronic obstructive pulmonary disease screening

• Registration Number: NCT04121117
• Lead Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Brief Summary

The aim of this study is to evaluate the usefulness of the chronic obstructive pulmonary disease-population questionnaire (COPD-PS) and the COPD-6 device in the early detection of chronic obstructive pulmonary disease in smoker patients .

Detailed Description

Not available

Study Timeline

• Status Verified: 2019-09
• Study First Submitted: 2019-10-02
• Study First Submitted QC: 2019-10-08
• Study First Posted: 2019-10-09
• Last Update Submitted: 2019-10-09
• Last Update Posted: 2019-10-11
• Study Start: 2019-10-15
• Primary Completion: 2020-03-15
• Study Completion: 2020-06-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 245

Inclusion Criteria

• > 35 years old
• Accumulative tobacco rate > 10 paq-year that go to the tobacco detoxication consultation

Exclusion Criteria

• Unable to fulfill the questionnarie
• Unable to adequately perform the COPD-6 or forced spirometry maneuvers included in the study.
• Reject to participate and sign the informed consent.

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Tobacco detoxication cohort	Chronic obstructive pulmonary disease screening	Patients appointed in a tobacco detoxication consultation

Primary Outcome Measures

Name	Time	Method
Evaluate the usefulness in the COPD early detection of the combination of the COPD-PS questionnaire and the COPD-6 device.	Up to 12 months after the first consultation	Verify if the combination of the COPDS-questionnaire (made of different items that allow the detection of chronic airflow obstruction) and the COPD-6 device (tool that measures the ventilatory capacity) is suitable for the COPD early detection.

Trial Locations

Locations (1)

Hospital Universitario Virgen Macarena; 🇪🇸 Sevilla, Spain